Tirzepatide | GIP & GLP-1 Weight Management

Tirzepatide is a peptide-based medication studied for weight management, appetite, blood sugar control, and metabolic health. It works with two of the body’s natural hormone pathways involved in hunger, digestion, insulin response, and how the body manages energy.

In scientific terms, tirzepatide is a dual agonist of the GIP and GLP-1 receptors. Clinical research has examined its effects on body weight, glycemic control, appetite, insulin sensitivity, and other metabolic measures. Its dual-receptor activity distinguishes it from compounds that primarily target GLP-1 alone.

Product contents: Contains 30 mg total in 3 mL of liquid (10 mg/mL).

Explore the Tirzepatide research →